Clinical Trials Browser

Phase 2 × Has results × darinaparsin × Clear all

NCT02653976 2024-01-26

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 2 Completed

67 enrolled 13 charts

Lymphoma, T-Cell, Peripheral